49 Wealth Management, LLC Nektar Therapeutics Transaction History
49 Wealth Management, LLC
- $830 Billion
- Q1 2025
A detailed history of 49 Wealth Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, 49 Wealth Management, LLC holds 81,740 shares of NKTR stock, worth $65,392. This represents 0.01% of its overall portfolio holdings.
Number of Shares
81,740Holding current value
$65,392% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
156Shares Held
130MCall Options Held
92.7KPut Options Held
4.9K-
Black Rock Inc. New York, NY15.2MShares$12.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$9.86 Million0.0% of portfolio
-
Samlyn Capital, LLC New York, NY9.67MShares$7.73 Million0.14% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT7.81MShares$6.25 Million0.37% of portfolio
-
Acadian Asset Management LLC Boston, MA7.2MShares$5.76 Million0.02% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $150M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...